Baidu
map

JAHA:晕厥患者再住院的相关因素研究

2018-09-12 MedSci MedSci原创

晕厥患者占了美国住院患者的0.6%-1.5%,本研究的目的旨在评估导致晕厥患者再住院的因素和预测因子。本研究纳入了数据库中2013年-2014年282311名原发性晕厥住院患者,平均年龄为72岁,女性占53.9%,其中9.3%的患者有过30天内再住院情况。分析结果显示,30天再住院的最常见原因是晕厥,其次是心源性、神经源性和感染源性因素。与30天再住院相关的因素包括年龄≥65岁([OR], 0.7

晕厥患者占了美国住院患者的0.6%-1.5%,本研究的目的旨在评估导致晕厥患者再住院的因素和预测因子。

本研究纳入了数据库中2013年-2014年282311名原发性晕厥住院患者,平均年龄为72岁,女性占53.9%,其中9.3%的患者有过30天内再住院情况。分析结果显示,30天再住院的最常见原因是晕厥,其次是心源性、神经源性和感染源性因素。与30天再住院相关的因素包括年龄≥65岁([OR], 0.7; 95% [CI], 0.6-0.7)、女性(OR, 0.9; 95% CI, 0.8-0.9)、充血性心衰(OR, 1.5; 95% CI, 1.2-1.9)、房颤(OR, 1.3; 95% CI, 1.3-1.4)、糖尿病(OR, 1.2; 95% CI, 1.2-1.3)、冠心病(OR, 1.2; 95% CI, 1.2-1.3)、贫血(OR, 1.4; 95% CI, 1.4-1.5)、慢阻肺(OR, 1.4; 95% CI, 1.3-1.4)、不遵医嘱(OR, 1.7; 95% CI, 1.6-1.9)和有医疗保险(OR, 0.6; 95% CI, 0.6-0.7)。

研究结果显示,晕厥患者的30天再住院率为9.3%,本研究也揭示了几个与30天再住院率相关的因素。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1267917, encodeId=3abb126e917b5, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311638, encodeId=dff91311638b3, content=<a href='/topic/show?id=053f59e677a' target=_blank style='color:#2F92EE;'>#晕厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59767, encryptionId=053f59e677a, topicName=晕厥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457495, encodeId=92a3145e49575, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344652, encodeId=ce0f34465207, content=值得学习与借鉴的临床经验,受益匪浅,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/27/c53a212859edcad4f60a54feffff50bb.jpg, createdBy=67cf1525321, createdName=13718711b3m, createdTime=Wed Sep 12 13:11:37 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344630, encodeId=c2ca34463075, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Wed Sep 12 09:45:20 CST 2018, time=2018-09-12, status=1, ipAttribution=)]
    2018-09-14 zhaohui6731
  2. [GetPortalCommentsPageByObjectIdResponse(id=1267917, encodeId=3abb126e917b5, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311638, encodeId=dff91311638b3, content=<a href='/topic/show?id=053f59e677a' target=_blank style='color:#2F92EE;'>#晕厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59767, encryptionId=053f59e677a, topicName=晕厥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457495, encodeId=92a3145e49575, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344652, encodeId=ce0f34465207, content=值得学习与借鉴的临床经验,受益匪浅,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/27/c53a212859edcad4f60a54feffff50bb.jpg, createdBy=67cf1525321, createdName=13718711b3m, createdTime=Wed Sep 12 13:11:37 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344630, encodeId=c2ca34463075, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Wed Sep 12 09:45:20 CST 2018, time=2018-09-12, status=1, ipAttribution=)]
    2018-09-14 lily1616
  3. [GetPortalCommentsPageByObjectIdResponse(id=1267917, encodeId=3abb126e917b5, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311638, encodeId=dff91311638b3, content=<a href='/topic/show?id=053f59e677a' target=_blank style='color:#2F92EE;'>#晕厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59767, encryptionId=053f59e677a, topicName=晕厥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457495, encodeId=92a3145e49575, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344652, encodeId=ce0f34465207, content=值得学习与借鉴的临床经验,受益匪浅,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/27/c53a212859edcad4f60a54feffff50bb.jpg, createdBy=67cf1525321, createdName=13718711b3m, createdTime=Wed Sep 12 13:11:37 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344630, encodeId=c2ca34463075, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Wed Sep 12 09:45:20 CST 2018, time=2018-09-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1267917, encodeId=3abb126e917b5, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311638, encodeId=dff91311638b3, content=<a href='/topic/show?id=053f59e677a' target=_blank style='color:#2F92EE;'>#晕厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59767, encryptionId=053f59e677a, topicName=晕厥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457495, encodeId=92a3145e49575, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344652, encodeId=ce0f34465207, content=值得学习与借鉴的临床经验,受益匪浅,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/27/c53a212859edcad4f60a54feffff50bb.jpg, createdBy=67cf1525321, createdName=13718711b3m, createdTime=Wed Sep 12 13:11:37 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344630, encodeId=c2ca34463075, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Wed Sep 12 09:45:20 CST 2018, time=2018-09-12, status=1, ipAttribution=)]
    2018-09-12 13718711b3m

    值得学习与借鉴的临床经验,受益匪浅,谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1267917, encodeId=3abb126e917b5, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311638, encodeId=dff91311638b3, content=<a href='/topic/show?id=053f59e677a' target=_blank style='color:#2F92EE;'>#晕厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59767, encryptionId=053f59e677a, topicName=晕厥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457495, encodeId=92a3145e49575, content=<a href='/topic/show?id=4159e25296d' target=_blank style='color:#2F92EE;'>#相关因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72529, encryptionId=4159e25296d, topicName=相关因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19655942413, createdName=zzc2213, createdTime=Fri Sep 14 00:23:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344652, encodeId=ce0f34465207, content=值得学习与借鉴的临床经验,受益匪浅,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/27/c53a212859edcad4f60a54feffff50bb.jpg, createdBy=67cf1525321, createdName=13718711b3m, createdTime=Wed Sep 12 13:11:37 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=344630, encodeId=c2ca34463075, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Wed Sep 12 09:45:20 CST 2018, time=2018-09-12, status=1, ipAttribution=)]
    2018-09-12 lietome15

    好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。

    0

相关资讯

JACC:冠心病患者低舒张压与心绞痛呈相关性

在冠心病患者中,低舒张压与心梗发生风险增高相关,但其与心绞痛的关系尚不清楚。本研究目的旨在评估冠心病患者的低舒张压与心绞痛的相关性。本研究纳入了1259名心绞痛的门诊患者,并根据舒张压对其心绞痛频率进行评估。在所有冠心病患者中,共有411名(33%)在最初的一个月内有出现心绞痛,且在最低舒张压患者中比例更高(40 - 64 mm Hg: 37%)。在非调整模型中,心绞痛与舒张压呈J型相关(p =

心血管疾病是中国人头号死因,专家:预防、康复应与治疗并重

心血管疾病是中国乃至全球的头号死因。在中国,心脑血管疾病引起的死亡占总死亡人数的40%,且患病率依然处于持续上升阶段。9月4日,在中国医学科学院阜外医院、德国北威州心脏和糖尿病中心、无锡明慈心血管病医院共同主办的“第三届中德医疗交流研讨会”上,澎湃新闻(www.thepaper.cn)记者获悉了上述消息。专家们认为,心血管病负担的日渐加重,无疑促使政府将治疗心血管疾病作为公共卫生的重中之重。但如

JACC:妊高症和女性心血管风险的预测

妊高症(HDP)影响了10%-15%的女性健康,且可增加2倍的心血管疾病发生风险。本研究的目的旨在评估将HDP纳入现有心血管风险评估体系中是否能提高女性心血管疾病发生的预测价值。本研究纳入了Nurses' Health Study II研究中的67406名年龄≥40岁无心血管基础疾病的女性,随访观察其心梗、冠心病和卒中的发生情况。本研究采用了2中心血管风险评分模型:模型A包括年龄、总胆固醇和高密度

JACC:2017美国心脏病学会血压指南有助于房颤患者的血压管理

2017年美国心脏病学会(ACC/AHA)的血压指南中推荐高血压的重新定义为收缩压≥130mmHg或舒张压≥80mmHg,但对于房颤患者来说,什么样的血压才是理想的尚不清楚。本研究纳入分析了2005年至2015年298374名韩国接受口服抗凝药治疗的房颤患者,根据最新的指南,其中有79.4%的患者为高血压,包括17.2%的患者为新定义的高血压(130 - 139/80 - 89 mm Hg)。与非

JAHA:皮肤自发荧光衡量的晚期糖基化终产物可作为高风险受试者心血管和全因死亡率的预测因子

由此可见,该分析的数据表明皮肤自发荧光水平可被作为高风险和极高风险患者全因死亡率和心血管死亡率的预测因子。

盘点:JACC9月第2期(血压专场)研究一览

1. 2017年美国血压指南推荐情况与心血管疾病风险DOI: 10.1016/j.jacc.2018.05.074http://www.onlinejacc.org/content/72/112017年美国心脏病学会(ACC/AHA)血压指南更新了抗高血压药物治疗的时机和强度。本研究的目的旨在比较和评估被2017 ACC/AHA指南推荐抗高血压治疗或不推荐的患者的心血管疾病发生风险。本研究纳入

Baidu
map
Baidu
map
Baidu
map